SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 16th, 2004 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 14, 2004, among Genta Incorporated, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and
William Keane Chief Financial Officer Genta lncorporated Two Connell Drive Berkeley Heights, NJ 07922 December 6,2004Introduction Agreement • December 16th, 2004 • Genta Inc De/ • Biological products, (no disgnostic substances)
The purpose of this letter agreement (the "Agreement") is to set forth the terms and conditions pursuant to which Rodman & Renshaw, LLC ("R&R) shall introduce Genta lncorporated (the "Company") to one or more investors in connection with the proposed offering (the "Offering") of securities (the "Securities") of the Company. The terms of such Offering and the Securities shall be mutually agreed upon by the Company and the investor(s). R&R's engagement under this Agreement shall be exclusive until December 15, 2004, and thereafter shall be non-exclusive. The identities of the investors to which R&R introduces the Company shall be proprietary information of R&R and shall not be divulged to third parties by the Company, nor used by the Company outside the scope of R&R's engagement as described herein.
